← Evidence map

ArticleExpert opinion on pharmacotherapy2022

What are the pharmacotherapeutic considerations for the treatment of myasthenia gravis?

Fiammetta Vanoli et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

6 papers cite it

2022
2023
2024
2025
2026
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 36104973